Department of Psychiatry and Behavioral Sciences

September 8, 2022

Juárez named director of behavior analysis

Pablo Juárez, MEd, BCBA, LBA, has been named director of behavior analysis within the Vanderbilt Kennedy Center and the Division of Developmental Medicine at Vanderbilt University Medical Center.

By Courtney Taylor
April 28, 2022

ASD study explores link between repetitive motion, depression

A Vanderbilt found that research into depression risk and resilience factors for adults with ASD is also critical to guide proper screening and intervention efforts.

By Emily Stembridge
autism concept: puzzle
April 21, 2022

Children with autism report greater gender diversity: study

Vanderbilt researchers found that children with autism report higher rates of gender diversity — the way in which an individual experiences gender distinct from social norms for their gender assigned at birth — than their typically developing peers.

By Emily Stembridge
April 21, 2022

Taylor, Newhouse, Petrie honored by geriatric psychiatry association

Vanderbilt’s Warren Taylor, MD, MHSc, Paul Newhouse, MD, and William Petrie, MD, were recently honored at the 2022 American Association for Geriatric Psychiatry (AAGP) Awards.

By Emily Stembridge
April 13, 2022

Study compares moral injury in health care workers and veterans

A study comparing 618 military veterans who deployed to a combat zone after Sept. 11, 2001, and 2,099 health care workers (HCWs) working during the COVID-19 pandemic found similar levels of potential moral injury (PMI), with 46.1% of veterans and 50.7% of HCWs reporting PMI.

By Emily Stembridge
February 28, 2022

VUMC mourns loss of former Psychopharmacology director Ban

Thomas Arthur Ban, MD, emeritus professor of Psychiatry and former director of Vanderbilt’s Division of Psychopharmacology, died Feb. 4. He was 92.

By Kathy Whitney
January 27, 2022

White matter and psychosis

The microstructure of white matter in the brain could be an important risk marker for psychosis, Vanderbilt researchers have discovered.
By Emily Stembridge
December 2, 2021

Study links depression scores, white blood cell count

By Emily Stembridge
September 30, 2021

Project seeks to treat Alzheimer’s in people with Down syndrome

A joint project between the Vanderbilt Kennedy Center and the Vanderbilt Center for Cognitive Medicine will help deliver Alzheimer’s disease therapies and treatments to people with Down syndrome (DS). 
By Emily Stembridge
September 20, 2021

Brain circuits in schizophrenia

Vanderbilt psychiatrists are probing brain circuit hyperactivity implicated in schizophrenia, with the idea that normalizing the hyperactivity may improve cognitive processes.
By Leigh MacMillan
September 2, 2021

White matter and schizophrenia

Patients with schizophrenia have functional changes in the white matter of the brain, Vanderbilt researchers have discovered, which may contribute to impaired working memory and processing speed.
By Emily Stembridge
August 23, 2021

Estrogen, depression and menopause

A shift in emotional processing may help women adapt to lower estrogen after menopause —unless they have a history of major depressive disorder, Vanderbilt researchers have found.
By Emily Stembridge
August 5, 2021

NIMH support bolsters early psychosis research efforts

The Department of Psychiatry and Behavioral Sciences has received an additional $4 million from the National Institute of Mental Health (NIMH) to study the evolution of hippocampal dysfunction in the early stage of psychosis.
By Emily Stembridge
1 2 3 4 5 … 12